Latest News and Press Releases
Want to stay updated on the latest news?
-
REYKJAVIK, ICELAND (July 10, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced...
-
REYKJAVIK, ISLAND UND BURGDORF, SCHWEIZ (9. JULI 2025) — Alvotech (NASDAQ: ALVO), ein globales Biotech-Unternehmen, das sich auf die Entwicklung und Herstellung von Biosimilars für Patienten weltweit...
-
REYKJAVIK, ISLAND OCH BURGDORF, SCHWEIZ (9 JULI 2025) — Alvotech (NASDAQ: ALVO SDB), ett globalt biofarmaceutiskt företag som specialiserar sig på utveckling och tillverkning av biosimilära...
-
Ivers-Lee er rótgróið fjölskyldufyrirtæki með höfuðstöðvar í Sviss og útibú í ÞýskalandiMeð kaupunum býr Alvotech sig undir mikinn vöxt eftirspurnar og eykur afköst í samsetningu og pökkun REYKJAVIK...
-
REYKJAVIK, ICELAND AND BURGDORF, SWITZERLAND (JULY 9, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients...
-
Alvotech acquires capability and added flexibility in assembly and packaging with acquisition of Ivers-Lee Group
-
Luxembourg (July 3, 2025) – Alvotech S.A. announces that on June 25, 2025, the proportion of own shares held by Alvotech S.A. reached 6.73%, crossing above the 5% threshold of the total number of...
-
Í samræmi við starfskjarastefnu sem samþykkt var á aðalfundi Alvotech þann 6. júní 2023 og þar sem nýtt starfsár stjórnar hefst með aðalfundi, voru á aðalfundi félagsins sem haldinn var 25. júní sl....
-
In accordance with the Remuneration Policy of Alvotech (the “Company”), which was approved at the Company’s Annual General Meeting (“AGM”) on June 6, 2023, at the 2025 AGM held on June 25, 2025, four...
-
REYKJAVÍK og LONDON, BRETLANDI (1. júlí 2025) - Alvotech (NASDAQ: ALVO) og Advanz Pharma tilkynntu í dag að félögin hafi gert með sér samning um markaðssetningu AVT10 í Evrópu. AVT10 er hliðstæða við...